Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Urvi Gupta, Sayan Ghosh, Callen T. Wallace, Peng Shang, Ying Xin, Archana Padmanabhan Nair, Meysam Yazdankhah, Anastasia Strizhakova, Mark A. Ross, Haitao Liu, Stacey Hose, Nadezda A. Stepicheva, Olivia Chowdhury, Mihir Nemani, Vishnu Maddipatla, Rhonda Grebe, Manjula Das, Kira L. Lathrop, José-Alain Sahel, J. Samuel Zigler$suffix/text()$suffix/text(), Jiang Qian, Arkasubhra Ghosh, Yuri Sergeev, James T. Handa, Claudette M. St. Croix & Debasish Sinha. (2023) Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD. Autophagy 19:1, pages 92-111.
Read now
Read now
Isita Tripathy, Amrita Panja, Tuphan Kanti Dolai & Asim Kumar Mallick. (2021) Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali β-Thalassemia Major Children. Hemoglobin 45:5, pages 296-302.
Read now
Read now
Karim Bayanzay & Lama Alzoebie. (2016) Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives. Journal of Blood Medicine 7, pages 159-169.
Read now
Read now
Emmanuel S. Hatzipantelis, Konstantinos Karasmanis, Vassilios Perifanis, Efthimia Vlachaki, Konstantinos Tziomalos & Marina Economou. (2014) Combined Chelation Therapy with Deferoxamine and Deferiprone in β-Thalassemia Major: Compliance and Opinions of Young Thalassemic Patients. Hemoglobin 38:2, pages 111-114.
Read now
Read now
Khaled M. Musallam & Ali T. Taher. (2011) Iron Chelation Therapy for Transfusional Iron Overload: A Swift Evolution. Hemoglobin 35:5-6, pages 565-573.
Read now
Read now
Articles from other publishers (23)
Piyush Kumar Yadav, Suchitra Singh & Ajay Kumar Singh. (2023) ‘3D-QSAR-based, pharmacophore modelling, virtual screening, and molecular docking studies for identification of hypoxia-inducible factor-1 inhibitor with potential bioactivity. Computers in Biology and Medicine 166, pages 107557.
Crossref
Crossref
Hariprasath Prakash, Anna Skiada, Raees Ahmad Paul, Arunaloke Chakrabarti & Shivaprakash Mandya Rudramurthy. (2021) Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis. Journal of Fungi 7:8, pages 616.
Crossref
Crossref
Sarah A. Taylor, Michael R. Narkewicz & Cara L. Mack. 2021. Liver Disease in Children. Liver Disease in Children
515
529
.
Matthew B. Nodwell & Robert Britton. (2020) Enterobactin on a Bead: Parallel, Solid Phase Siderophore Synthesis Reveals Structure–Activity Relationships for Iron Uptake in Bacteria. ACS Infectious Diseases 7:1, pages 153-161.
Crossref
Crossref
Francesca Vinchi, Saskia Hell & Uwe Platzbecker. (2020) Controversies on the Consequences of Iron Overload and Chelation in MDS. HemaSphere 4:3, pages e357.
Crossref
Crossref
Changjun Guo, Kai Yang, Yufei Yan, Dongming Yan, Yifan Cheng, Xueming Yan, Niandong Qian, Qi Zhou, Bo Chen, Min Jiang, Hanbing Zhou, Changwei Li, Fei Wang, Jin Qi, Xiangyang Xu & Lianfu Deng. (2019) SF-deferoxamine, a bone-seeking angiogenic drug, prevents bone loss in estrogen-deficient mice. Bone 120, pages 156-165.
Crossref
Crossref
Andrea Pagani, Matthias M. Aitzetmüller, Elizabeth A. Brett, Viktoria König, Raphael Wenny, Dominik Thor, Christine Radtke, Georg M. Huemer, Hans-Günther Machens & Dominik Duscher. (2018) Skin Rejuvenation through HIF-1α Modulation. Plastic & Reconstructive Surgery 141:4, pages 600e-607e.
Crossref
Crossref
Nupur Parakh, Jagdish Chandra, Sunita Sharma, Bhavna Dhingra, Rajesh Jain & DeoNath Mahto. (2017) Efficacy and Safety of Combined Oral Chelation With Deferiprone and Deferasirox in Children With β-Thalassemia Major: An Experience From North India. Journal of Pediatric Hematology/Oncology 39:3, pages 209-213.
Crossref
Crossref
Kayleigh E. Jones, Kathleen L. Batchler, Célia Zalouk & Ann M. Valentine. (2017) Ti(IV) and the Siderophore Desferrioxamine B: A Tight Complex Has Biological and Environmental Implications. Inorganic Chemistry 56:3, pages 1264-1272.
Crossref
Crossref
Josef Lichtmannegger, Christin Leitzinger, Ralf Wimmer, Sabine Schmitt, Sabine Schulz, Yaschar Kabiri, Carola Eberhagen, Tamara Rieder, Dirk Janik, Frauke Neff, Beate K. Straub, Peter Schirmacher, Alan A. DiSpirito, Nathan Bandow, Bipin S. Baral, Andrew Flatley, Elisabeth Kremmer, Gerald Denk, Florian P. Reiter, Simon Hohenester, Friedericke Eckardt-Schupp, Norbert A. Dencher, Jerzy Adamski, Vanessa Sauer, Christoph Niemietz, Hartmut H.J. Schmidt, Uta Merle, Daniel Nils Gotthardt, Guido Kroemer, Karl Heinz Weiss & Hans Zischka. (2016) Methanobactin reverses acute liver failure in a rat model of Wilson disease. Journal of Clinical Investigation 126:7, pages 2721-2735.
Crossref
Crossref
Sidharth Totadri, Deepak Bansal, Prateek Bhatia, Savita V. Attri, Amita Trehan & R. K. Marwaha. (2015) The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study. Pediatric Blood & Cancer 62:9, pages 1592-1596.
Crossref
Crossref
Ying Zhang, Hao Wang, Lijing Cui, Yuanyuan Zhang, Yang Liu, Xi Chu, Zhenyi Liu, Jianping Zhang & Li Chu. (2015) Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice. PLOS ONE 10:4, pages e0124061.
Crossref
Crossref
Michael R. Narkewicz & Peter F. Whittington. 2014. Liver Disease in Children. Liver Disease in Children
493
508
.
Michael R. Narkewicz & Christine Waasdorp Hurtado. 2014. Diseases of the Liver in Children. Diseases of the Liver in Children
185
214
.
Kelsey J. WeigelSharon G. LynchSteven M. LeVine. (2014) Iron Chelation and Multiple Sclerosis. ASN Neuro 6:1, pages AN20130037.
Crossref
Crossref
Sneha Dadheech, A. Venkateswara Rao, Uzma Shaheen, Mohammed Dyia Hussien, Suman Jain, A. Jyothy & Anjana Munshi. (2013) Three most common nonsynonymous UGT1A6*2 polymorphisms (Thr181Ala, Arg184Serand Ser7Ala) and therapeutic response to deferiprone in β-thalassemia major patients. Gene 531:2, pages 301-305.
Crossref
Crossref
Juliano Lara Fernandes. (2012) Iron chelation therapy in the management of transfusion-related cardiac iron overload. Transfusion 52:10, pages 2256-2268.
Crossref
Crossref
Elena Cassinerio, Alberto Roghi, Patrizia Pedrotti, Francesca Brevi, Laura Zanaboni, Giovanna Graziadei, Paolo Pattoneri, Angela Milazzo & Maria Domenica Cappellini. (2012) Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients. Annals of Hematology 91:9, pages 1443-1449.
Crossref
Crossref
Hyoung-Joon Chun, Dong Won Kim, Hyeong-Joong Yi, Young Soo Kim, Eun Hyun Kim, Se Jin Hwang, Cheol-Su Jwa, Yoon Kyoung Lee & Hyunchul Ryou. (2011) Effects of statin and deferoxamine administration on neurological outcomes in a rat model of intracerebral hemorrhage. Neurological Sciences 33:2, pages 289-296.
Crossref
Crossref
Rachid Haidar, Hani Mhaidli, Khaled M. Musallam & Ali T. Taher. (2012) The Spine in β-Thalassemia Syndromes. Spine 37:4, pages 334-339.
Crossref
Crossref
Patrick A. Rowe, Kylie Kavanagh, Li Zhang, H. James HarwoodJr.Jr. & Janice D. Wagner. (2011) Short-term hyperglycemia increases arterial superoxide production and iron dysregulation in atherosclerotic monkeys. Metabolism 60:8, pages 1070-1080.
Crossref
Crossref
P. J. Ho, L. Tay, R. Lindeman, L. Catley & D. K. Bowden. (2011) Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias. Internal Medicine Journal 41:7, pages 516-524.
Crossref
Crossref
Rachid Haidar, Khaled M. Musallam & Ali T. Taher. (2011) Bone disease and skeletal complications in patients with β thalassemia major. Bone 48:3, pages 425-432.
Crossref
Crossref